Both in Surgical Instruments
Pulmonx vs Lucid Diagnostics
Over the past year LUNG returned +64.5% and LUCD returned −59.9%; their daily moves had a correlation of 0.13.
LUNG +64.5% LUCD −59.9%Growth of $1, one year, split-adjusted
| Metric | LUNG | LUCD |
|---|---|---|
| Price | $2.83 | $0.4451 |
| Market cap | $121.5M | $85.0M |
| Today | +4.04% | +8.83% |
| 1 month | +59.0% | −25.8% |
| 6 months | +119.4% | −58.8% |
| Year to date | +28.1% | −59.2% |
| 1 year | +54.6% | −63.2% |
| Revenue growth (YoY) | −4.6% | +26.7% |
| Gross margin | 78.0% | 2.0% |
| Net margin | −44.3% | −998.3% |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | 15.6× |
| Net cash | $18.3M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 96.9% | 109.9% |
| Short % of float | 1.8% | 8.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).